The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma

BACKGROUND: Sorafenib and transarterial chemoembolization (TACE) are recommended therapies for advanced hepatocellular carcinoma (HCC), but their combined efficacy remains unclear. METHODS: Between August 2004 and November 2014, 104 patients with BCLC stage B/C HCC were enrolled at the Affiliated Tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Fei-Xiang, Chen, Jie, Bai, Tao, Zhu, Shao-Liang, Yang, Tian-Bo, Qi, Lu-Nan, Zou, Ling, Li, Zi-Hui, Ye, Jia-Zhou, Li, Le-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596482/
https://www.ncbi.nlm.nih.gov/pubmed/28899349
http://dx.doi.org/10.1186/s12885-017-3545-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596482/
https://www.ncbi.nlm.nih.gov/pubmed/28899349
http://dx.doi.org/10.1186/s12885-017-3545-5

Ejemplares similares